Vu Dung, Bolton-Maggs Paula H B, Parr Jeremy R, Morris Michael A, de Moerloose Philippe, Neerman-Arbez Marguerite
Centre Médical Universitaire, 1 rue Michel Servet, CH-1211 Geneva, Switzerland.
Blood. 2003 Dec 15;102(13):4413-5. doi: 10.1182/blood-2003-06-2141. Epub 2003 Jul 31.
Congenital afibrinogenemia is a rare autosomal recessive disorder characterized by complete absence of detectable fibrinogen. We previously identified the first causative mutations for this disease: a homozygous deletion of approximately 11 kb of the fibrinogen alpha-chain gene (FGA). Subsequent studies revealed that the great majority of afibrinogenemia mutations are localized in FGA, but mutations were also found in FGG and FGB. Apart from 3 missense mutations identified in the C-terminal portion of FGB, all fibrinogen gene mutations responsible for afibrinogenemia are null. In this study, a young boy with afibrinogenemia was found to be a compound heterozygote for 2 mutations in FGB: an N-terminal nonsense mutation W47X (exon 2) and a missense mutation (G444S, exon 8). Coexpression of the FGB G444S mutant cDNA in combination with wild-type FGA and FGG cDNAs demonstrated that fibrinogen molecules containing the mutant beta chain are able to assemble but are not secreted into the media, confirming the pathogenic nature of the identified mutation.
先天性无纤维蛋白原血症是一种罕见的常染色体隐性疾病,其特征是完全检测不到纤维蛋白原。我们之前鉴定出了该疾病的首个致病突变:纤维蛋白原α链基因(FGA)约11 kb的纯合缺失。随后的研究表明,绝大多数无纤维蛋白原血症突变定位于FGA,但在FGG和FGB中也发现了突变。除了在FGB C末端部分鉴定出的3个错义突变外,所有导致无纤维蛋白原血症的纤维蛋白原基因突变均为无效突变。在本研究中,一名患有无纤维蛋白原血症的小男孩被发现是FGB中2个突变的复合杂合子:一个N末端无义突变W47X(第2外显子)和一个错义突变(G444S,第8外显子)。FGB G444S突变体cDNA与野生型FGA和FGG cDNA共表达表明,含有突变β链的纤维蛋白原分子能够组装,但不会分泌到培养基中,证实了所鉴定突变的致病性质。